Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy

NCT05846997 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-05-06

No results posted yet for this study

Summary

The purpose of the study is the identification of novel micro-invasive predictors of pathological complete response (pCR) during neo-adjuvant therapy

Conditions

Interventions

DIAGNOSTIC_TEST

Liquid biopsy and imaging

Liquid biopsy and imaging

Sponsors & Collaborators

  • Centro di Riferimento Oncologico - Aviano

    lead OTHER

Principal Investigators

  • Milena Nicoloso, MD · Centro di Riferimento Oncologico - Aviano

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2023-12-31
Completion
2025-02-24

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05846997 on ClinicalTrials.gov